AZALEP a randomized controlled trial of azathioprine to treat leprosy nerve damage and Type 1 reactions in India: Main findings

BACKGROUND: Leprosy Type 1 reactions are difficult to treat and only 70% of patients respond to steroid treatment. Azathioprine has been used as an immune-suppressant and we tested its efficacy in treating leprosy T1R. METHODOLOGY: Randomised controlled trial adding azathioprine to steroid treatment...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS Negl Trop Dis
Autori principali: Lockwood, Diana N. J., Darlong, Joydeepa, Govindharaj, Pitchaimani, Kurian, Royce, Sundarrao, Pamidipani, John, Annamma S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5373510/
https://ncbi.nlm.nih.gov/pubmed/28358815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0005348
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi